Heart Failure
Studies from State University of New York provide new data on heart failure
Published in Cardiovascular Device Liability Week, September 20th, 2009
"We conducted a randomized controlled trial of patients with acute heart failure in 10 academic and community ernergency departments. The experimental group received serial B-type natriuretic peptide testing (at 3, 6, 9, and 12 hours then daily). The control group received usual care. Our outcomes were hospital length of stay, 30-day readmission rate, and all-cause mortality. There were 219 controls and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Diabetes
National Changing Diabetes Program Supports Improvements in Health Cost Estimates - HealthPartners
HealthPartners: Spreading Care System Redesign Reforms Nationwide Could Save up to $2.4 Trillion over Next Decade - Heart Bypass Surgery
New data from K. Chalkidou et al illuminate research in heart bypass surgery - Phillips & Cohen Llp
Bextra Whistleblower Case Started Investigation of Pfizer - Abdominal Aortic Aneurysm
Reports outline abdominal aortic aneurysm study findings from University Medical Center - Abiomed, Inc.
First Post-Trial AbioCor Patient Passes Away - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
